Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Diabetes Care
|
October 14, 2011
Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes
Gary E Meininger, Russell Scott, Maria Alba, et al.
Journal of Diabetes
|
June 8, 2012
The addition of sitagliptin to ongoing metformin therapy significantly improves glycemic control in Chinese patients with type 2 diabetes
Wenying Yang, Yanfen Guan, Yue Shentu, et al.
Journal of Diabetes and Its Complications
|
November 3, 2012
Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes
Vivian Fonseca, Bart Staels, Jerry D Morgan, et al.
Journal of Diabetes
|
December 2, 2015
A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
Robert G Moses, Elizabeth Round, Yue Shentu, et al.
Statistics in Biopharmaceutical Research
|
June 30, 2021
Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework
Evgeny Degtyarev, Kaspar Rufibach, Yue Shentu, et al.
Clinical Lung Cancer
|
May 26, 2022
Rationale and Design of the Phase III KEYLYNK-012 Study of Pembrolizumab and Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Stage III Non-Small-Cell Lung Cancer
Salma K Jabbour, Byoung Chul Cho, Emilio Bria, et al.
Plos One
|
April 23, 2009
Genetic structures of copy number variants revealed by genotyping single sperm
Minjie Luo, Xiangfeng Cui, David Fredman, et al.
Pharmaceutical Statistics
|
October 4, 2021
Estimands for overall survival in clinical trials with treatment switching in oncology
Juliane Manitz, Natalia Kan-Dobrosky, Hannes Buchner, et al.
Statistics in Biopharmaceutical Research
|
June 30, 2021
Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic
R Daniel Meyer, Bohdana Ratitch, Marcel Wolbers, et al.
The New England Journal of Medicine
|
October 11, 2016
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Diabetes Care
|
October 14, 2011
Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes
Gary E Meininger, Russell Scott, Maria Alba, et al.
Journal of Diabetes
|
June 8, 2012
The addition of sitagliptin to ongoing metformin therapy significantly improves glycemic control in Chinese patients with type 2 diabetes
Wenying Yang, Yanfen Guan, Yue Shentu, et al.
Journal of Diabetes and Its Complications
|
November 3, 2012
Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes
Vivian Fonseca, Bart Staels, Jerry D Morgan, et al.
Journal of Diabetes
|
December 2, 2015
A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
Robert G Moses, Elizabeth Round, Yue Shentu, et al.
Statistics in Biopharmaceutical Research
|
June 30, 2021
Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework
Evgeny Degtyarev, Kaspar Rufibach, Yue Shentu, et al.
Clinical Lung Cancer
|
May 26, 2022
Rationale and Design of the Phase III KEYLYNK-012 Study of Pembrolizumab and Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Stage III Non-Small-Cell Lung Cancer
Salma K Jabbour, Byoung Chul Cho, Emilio Bria, et al.
Plos One
|
April 23, 2009
Genetic structures of copy number variants revealed by genotyping single sperm
Minjie Luo, Xiangfeng Cui, David Fredman, et al.
Pharmaceutical Statistics
|
October 4, 2021
Estimands for overall survival in clinical trials with treatment switching in oncology
Juliane Manitz, Natalia Kan-Dobrosky, Hannes Buchner, et al.
Statistics in Biopharmaceutical Research
|
June 30, 2021
Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic
R Daniel Meyer, Bohdana Ratitch, Marcel Wolbers, et al.
The New England Journal of Medicine
|
October 11, 2016
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, et al.
Page
of 3